Asymchem Laboratories (Tianjin) Co., Ltd. (HKG:6821)

Market Cap	30.05B
Revenue (ttm)	6.17B
Net Income (ttm)	851.80M
Shares Out	n/a
EPS (ttm)	2.39
PE Ratio	35.28
Forward PE	n/a
Dividend	1.98 (3.59%)
Ex-Dividend Date	Jun 13, 2024

Volume	319,800
Average Volume	506,318
Open	55.30
Previous Close	55.00
Day's Range	54.10 - 56.90
52-Week Range	37.60 - 79.15
Beta	0.19
RSI	50.64
Earnings Date	Mar 29, 2025

About HKG:6821

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers process development and optimization, analytical, and scale-up services for small molecule drug products throughout the pre-clinical and clinical stage; and ton-scale manufacturing services for registered starting materials, advanced intermediates, and active pharmaceutical ingredients. It also engages in pre-formulation and formulation development; provision of chemical m...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 9,788
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6821

Financial Performance

In 2023, HKG:6821's revenue was 7.83 billion, a decrease of -23.70% compared to the previous year's 10.26 billion. Earnings were 2.27 billion, a decrease of -31.28%.

Financial numbers in CNY